Fan Zhang, Ph.D.

AstraZeneca

Prior to her retirement in June 2023, Fan Zhang was the Head of Late Hematology Statistics, Oncology Biometrics, at AstraZeneca following the integration of Acerta Pharma, where she was the Vice President of Biometrics at Acerta Pharma, a Member of AstraZeneca Group, and led Biostatistics, Clinical Data Management and Statistical Programming functions and successfully achieved Calquence approvals in CLL in multiple countries simultaneously under FDA RTOR and Project Orbis pilots.  

Fan has over two decades of biopharma experience, including 18 years in oncology drug development for solid tumors and hematologic malignancies. Prior to joining Acerta, she grew and led the Data & Statistical Sciences group at AbbVie’s Redwood City and South San Francisco sites to support the oncology early development programs.

Before AbbVie, Fan spent over 10 years at Genentech with increasing responsibilities leading biostatistics in late stage oncology development and global regulatory submissions that resulted multiple successful product launches. Fan spent her formative years in the biopharma industry at Eli Lilly where she was the lead statistician for pivotal phase III clinical trials in neuroscience indications.

Fan received her M.S. and Ph.D. in Biostatistics with a minor in HIV/AIDS Research from UCLA School of Public Health.